Aidigong Maternal & Child Health Limited
HKSE 0286.HK
Aidigong Maternal & Child Health Limited Price to Sales Ratio (P/S) on January 14, 2025: 0.56
-
Aidigong Maternal & Child Health Limited 52-week high Price to Sales Ratio (P/S) is 4.05 on December 20, 2024, which is 628.04% above the current Price to Sales Ratio (P/S).
-
Aidigong Maternal & Child Health Limited 52-week low Price to Sales Ratio (P/S) is 0.48 on September 24, 2024, which is -13.09% below the current Price to Sales Ratio (P/S).
-
Aidigong Maternal & Child Health Limited average Price to Sales Ratio (P/S) for the last 52 weeks is 0.81.
| Date | Price to Sales Ratio (P/S) | Price to Book Ratio (P/B) | Dividend Yield | Free Cash Flow Yield |
|---|
| CEO | Ms. Aier Wang M.B.A. |
| IPO Date | Sept. 7, 1990 |
| Location | Hong Kong |
| Headquarters | YHC Tower |
| Employees | 1,338 |
| Sector | Consumer Staples |
| Industries | |
Aidigong Maternal & Child Health Limited, an investment holding company, provides postpartum care and healthcare services in the People's Republic of China and Hong Kong. It operates through Postpartum Care Services, Health Industry, and Other segments. The company offers maternal and child healthcare services; medical anti-aging services; healthcare industry investment services; and healthcare property development services, as well as trades in natural health food and pharmaceutical products. It also offers precision life healthcare, bio-medical technology, and management services, as well as investment and finance services. The company was formerly known as Common Splendor International Health Industry Group Limited and changed its name to Aidigong Maternal & Child Health Limited in December 2019. Aidigong Maternal & Child Health Limited is based in Kowloon Bay, Hong Kong.
Past 5 years
USD 0.18
USD 0.25
USD 0.62
StockViz Staff
January 16, 2025
Any question? Send us an email